Man Group’s Evolent Health EVH Stock Holding History

Man Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Buy	498,272 +401,395	+414%	+$1.54M	﹤0.01%	1424
2026 Q1	$221K	Buy	+96,877	New	+$307K	﹤0.01%	2282
2025 Q3	–	Sell	-36,235	Closed	-$408K	–	2286
2025 Q2	$408K	Sell	36,235 -2,794	-7%	-$25.7K	﹤0.01%	1888
2025 Q1	$370K	Buy	+39,029	New	+$394K	﹤0.01%	1885
2024 Q4	–	Sell	-491,382	Closed	-$13.9M	–	2045
2024 Q3	$13.9M	Sell	491,382 -708,927	-59%	-$18.3M	0.04%	587
2024 Q2	$22.9M	Buy	1,200,309 +1,150,396	+2,305%	+$29.4M	0.06%	391
2024 Q1	$1.64M	Buy	+49,913	New	+$1.59M	﹤0.01%	1383
2022 Q2	–	Hold	0	–	–	–	1836
2018 Q4	–	Sell	-51,028	Closed	-$1.45M	–	1971
2018 Q3	$1.45M	Buy	+51,028	New	+$1.22M	0.01%	1525

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Man Group's EVH Position: Q2 2026 in Review

Man Group increased its Evolent Health (EVH) stake by 414% in Q2 2026, buying an estimated $1.54M and bringing the position to 498,272 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

Man Group first reported a position in EVH in Q3 2018 and has held it in 8 quarters since. The position peaked at $22.9M in Q2 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Man Group held 498,272 shares of Evolent Health worth $2.7M as of Q2 2026.
Man Group bought 401,395 Evolent Health shares in Q2 2026, an estimated $1.54M.
Evolent Health made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1424 holding.
Man Group first reported a position in Evolent Health in Q3 2018 and has held it in 8 quarters since.
Man Group's Evolent Health position peaked at $22.9M in Q2 2024.
199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.